ESMO 2025: Data, decisions, and the future of oncology
This year’s congress showcased remarkable progress across multiple fronts, from next-generation immunotherapies and antibody-drug conjugates (ADCs) to the accelerating role of AI-driven…
All articles by Fi Forrest
Fi Forrest
Senior writer at GMS, GlobalData. Previously feature writer at Just Style. TABBIE Honourable Mention winner. BA (Open) in English | BSc (Hons) in Geosciences. Also a graphic designer with certificates in Digital Marketing and Social Media. Lives by the beach.
-
-
From the experts: How to successfully implement Annex 1 regulations
Annex 1 regulations refer to a set of guidelines from the European Medicines Agency (EMA) for the manufacture of sterile…
-
Advanced bioconjugation strategies: New webinar tackles complex chemistry for targeted therapeutics
In the fast-paced environment of pharmaceutical innovation, bioconjugation has proved to be a cornerstone technology. By enabling the precise modification…
-
Five key insights to unlock the secrets behind a successful commercial drug launch
The growing demand for contract packaging services is a testament to the added value CDMOs bring to pharmaceutical companies navigating…
-
Huawei’s three key steps to drive industrial intelligence forward and unleash AI’s full potential
Speaking at HUAWEI CONNECT 2025 in Shanghai, Leo Chen, Senior Vice President and President of Enterprise Sales at Huawei, reminded…
-
How the latest Frewitt FlexMills are crushing the opposition
High-speed and high-precision micro-milling (micronisation) play a crucial role in various industries, including pharmaceuticals, food production and the development of…
-
CDMO insights podcast series: Our Experience is Your Strength | Episode #1 Formulation
The early stages of formulation development and analytical testing can be some of the most exciting phases of drug development,…
-
Five lessons from biopharma companies’ data transformation journeys
Author: Sebastian Wurst, Director, OpenData Strategy, Europe As global biopharmas expand into new markets, they introduce more systems to handle…
-
How AI and machine learning are transforming drug discovery
AI is revolutionizing drug discovery with its ability to analyze vast datasets. Particularly beneficial in the early drug discovery phase,…
-
Introducing AI into the pharma supply chain is a journey
The proliferation of Artificial Intelligence (AI) in our lives has set about a true revolution in how we collect, organize…